Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2000
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051511A1 Methods of identifying modulators of kinases responsive to stress
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051419A1 Deprotection and recrystallization processes
11/15/2000EP1051416A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
11/15/2000EP1051415A1 Benzamide derivatives as vasopressin antagonists
11/15/2000EP1051405A2 Novel dihydroxyhexanoic acid derivatives
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000EP1051395A1 Hydroxamic and carboxylic acid derivatives
11/15/2000EP1051394A1 Potassium channel inhibitors
11/15/2000EP1051192A2 Methods for the prevention and treatment of fibrosis and sclerosis
11/15/2000EP1051188A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
11/15/2000EP1051186A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
11/15/2000EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/15/2000EP1051173A1 Derivatives of 1,3,4-oxadiazolone
11/15/2000EP1051168A2 Compositions, apparatus and methods for facilitating surgical procedures
11/15/2000EP1051165A2 Mitochondria protecting agents for treating mitochondria associated diseases
11/15/2000EP1051155A1 Nasal solutions
11/15/2000EP1051086A1 Dietetic composition in the form of a substitution salt for table salt
11/15/2000CN1273579A Anthranilic acid analogs
11/15/2000CN1273529A Vitronection receptor antagonist
11/15/2000CN1273122A Synthetic orall liquid of red sage root
11/15/2000CN1273119A Composite safflower oil preparation and medicine containing it
11/15/2000CN1273110A Chinese medicine for curing viral myocarditis
11/15/2000CN1273107A Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
11/15/2000CN1273098A Oral liquid for treating cerebral infarction
11/15/2000CN1058494C New diosmetin compound, process for their preparation and pharmaceutial compositions containing them
11/15/2000CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ
11/15/2000CN1058390C Use of compound of benzo-thiophenes
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147214 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147111 Kidney, brain, and cardiovascular disorders; vasodilation
11/14/2000US6147110 Heterocyclic compounds
11/14/2000US6147109 Treating impotency; brain, cardiovascular, respiratory system and gastrointestinal disorders
11/14/2000US6147099 Oxazolidinedione derivatives, their production and use
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/14/2000US6147092 Method for inhibiting estrogen-dependent cancer
11/14/2000US6147090 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147089 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147085 Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147075 Analgesics; psychological disorders
11/14/2000US6147073 Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors
11/14/2000US6147063 Therapeutic substituted guanidines
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146876 22025, a novel human cyclic nucleotide phosphodiesterase
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000CA2103458C Method and composition to reduce myocardial reperfusion injury
11/14/2000CA2080221C An improved process for the preparation of substituted indolone derivatives
11/09/2000WO2000066754A1 Protein c derivatives
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066734A1 Methods of treating hypertension
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066725A1 Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
11/09/2000WO2000066635A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066626A1 Novel peptide y-2
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066611A1 Steroid derivatives
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066585A1 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066582A1 Substituted pyrazole derivative
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066161A1 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066142A2 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
11/09/2000WO2000066138A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066132A1 Use of fragments of hyaluronic acid
11/09/2000WO2000066130A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
11/09/2000WO2000066128A1 Method of enhancing insulin action
11/09/2000WO2000066123A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor
11/09/2000WO2000066121A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000WO2000066118A1 Compositions for treating brain infarction
11/09/2000WO2000066117A1 Use of (2s)-1- [(2r,3s)-5-chloro-3- (2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy-2,3- dihydro-1h- indole-2-carbonyl] pyrrolidine- 2-carboxamide in the production of medicaments used to treat raynaud's phenomenon
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066078A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract
11/09/2000WO2000051968A8 Method for the preparation of a chiral-beta-amino ester
1 ... 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 ... 1595